Emotional Awareness and Expression Therapy for Chronic Pain and Opioid Use Disorder
CompletedNot applicableNCT06865560
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The study is intended to test whether a group-based Zoom behavioral treatment can help adults with chronic pain and opioid use disorder (OUD) learn effective strategies for reducing pain, disability and other problems that can come with these conditions (such as depression, anxiety, and difficulty managing emotions).
Study details
- Official title
- Emotional Awareness and Expression Therapy for Chronic Pain and Opioid Use Disorder - A Pilot Study
- Conditions
- Interventions
- Behavioral: Emotional Awareness and Expression Therapy (EAET)
- Sponsor
- University of Michigan
- Start date
- 2025-06-03
- Primary completion
- 2025-10-05
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Be able to read, write and speak English * Have Internet access and audio-visual conferencing capability (e.g., Zoom meetings by phone or computer) in the home * Widespread pain and has opioid use disorder (OUD) Exclusion Criteria: * Diagnosis of autoimmune disease, spinal cord injury, cancer. * Currently receiving cognitive-behavioral therapy, EAET, or other psychological therapies for pain * Open litigation regarding chronic pain in the past 1 year, as assessed in preliminary study screening. * Inability to provide informed consent and complete study procedures (e.g., indications of suspected major cognitive impairment via observations of study staff during consenting) that would preclude comprehension or participation in study protocols. * Pregnant or breastfeeding * Any other diseases or conditions that would make a patient unsuitable for study participation as determined by the site principal investigators.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06865560